Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. Omicron plan: boosters, free at-home tests, tighter travel rules

Stock MarketsDec 02, 2021 02:45PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. FILE PHOTO: A vial and a syringe are seen in front of a displayed United States' flag and words "Omicron SARS-CoV-2" in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration 2/2

WASHINGTON (Reuters) -The Biden administration on Thursday sought to ramp up its pandemic response following U.S. detection of the Omicron coronavirus variant this week, making at-home COVID-19 tests available free of charge, accelerating its push for booster shots and tightening rules for travelers.

Below are some of the key measures in the plan, released by the White House and unveiled by President Joe Biden at the National Institutes of Health:

FREE AT-HOME, OVER-THE-COUNTER TESTS

Private health insurance companies will be required to reimburse customers for the cost of over-the-counter at-home COVID-19 tests, the White House said, with the administration issuing federal guidance by Jan. 15.

For the uninsured, at-home tests will be made available at no charge at community testing sites.

At least eight over-the-counter rapid antigen tests have been approved by the U.S. Food and Drug Administration, including Abbott Laboratories (NYSE:ABT)' BinaxNOW, OraSure Technologies Inc's InteliSwab, ACON Laboratories' FlowFlex and Ellume's home test. Other manufacturers include Quidel (NASDAQ:QDEL) Corp, Becton Dickinson (NYSE:BDX) and Co, Celltrion Inc, iHealth Labs Inc and InBios International Inc.

Health insurers already cover the more accurate PCR tests done through laboratories that are not FDA-approved for at-home use.

WIDER PUSH FOR BOOSTER SHOTS

The U.S. Department of Health and Human Services along with pharmacy companies will launch a public information campaign to encourage booster shots, following the Centers for Disease Control and Prevention's (CDC) revised guidance this week recommending all adults get a booster.

Pharmacies will reach out to customers by text and e-mail and take steps to increase vaccine availability, including weekend and evening hours, according to the White House.

The government's Medicare insurance program for those over 65 and the disabled and the Medicaid program for low-income people will also make outreach efforts to encourage shots among the millions who rely on them.

Federal government employees will receive paid leave to get their booster shots, Biden said, urging private employers to do the same for their workers.

TIGHTER TRAVEL REQUIREMENTS

The U.S. CDC will require inbound international passengers be tested for COVID-19 within one day of departure, regardless of their vaccination status, sources separately told Reuters. Mask requirements on airplanes, trains and public transportation vehicles will be extended through March 18.

The new one-day testing requirement would apply to U.S. citizens as well as foreign nationals and could take effect as early as next week.

CDC officials also have ordered airlines to disclose passenger names and other information for those who have recently been in eight southern African countries that identified early Omicron cases and will provide it to local and state public health agencies.

MORE FAMILY VACCINATION CLINICS

The administration will launch hundreds of family vaccination clinics nationwide that will allow eligible parents, grandparents and children to get initial vaccines and booster shots with a "one-stop-shop," the White House said.

Community health centers will host the clinics throughout December. Mobile health clinics will also be deployed across the country, starting in Washington and New Mexico, according to the plan.

Retail pharmacies, including CVS Health Corp (NYSE:CVS) and Rite Aid (NYSE:RAD) Corp will start allowing family-based appointment scheduling, the White House said.

INCREASING TREATMENT SUPPLIES

The White House said any new COVID-19 treatment pills approved by U.S. regulators would be "equitably accessible to all Americans, regardless of their income or their zip code," adding that it was working to secure 13 million doses of antiviral courses.

Biden, speaking at NIH, said some doses already have been secured.

U.S. Omicron plan: boosters, free at-home tests, tighter travel rules
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email